scholarly journals AB1373 Urinary protein profile comparison between sle patients with and without renal involvement

Author(s):  
N. Rivera ◽  
E. Ruiz ◽  
E. Úcar ◽  
M.L. García Vivar ◽  
F. Elortza ◽  
...  
1983 ◽  
Vol 147 (1) ◽  
pp. 106-108 ◽  
Author(s):  
Robert D. Eden ◽  
Camille J. Wahbeh ◽  
James F. Barter ◽  
Ann Y. Williams ◽  
Allen P. Killam ◽  
...  

2018 ◽  
Vol 19 (1) ◽  
Author(s):  
Zhengguang Guo ◽  
Zhao Wang ◽  
Chen Lu ◽  
Shufen Yang ◽  
Haidan Sun ◽  
...  

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Hai-bo Yan ◽  
Yu-mei Li

Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple systems with various clinical manifestations. Renal involvement is common, but intracardiac thrombus is rarely reported as a complication of antiphospholipid syndrome (APS, also known as anticardiolipin syndrome). Anticoagulant therapy is the first-line treatment, and surgery is performed in severe cases. We report a case to improve clinicians’ understanding of disease diagnosis. Case presentation An 8-year-old girl was admitted to our hospital because of left costal pain, hematuria and fever. She had obvious edema occult blood 3+, urinary protein 3.2 g/24 h, albumin 17.6 g/L, and total cholesterol 7.21 mmol/L, consistent with a diagnosis of nephrotic syndrome. We continued to track the etiology of nephrotic syndrome and performed a renal biopsy, showing dsDNA 1:10 positivity, low C3, low platelets and hemoglobin, anticardiolipin IgM 12 U/ml, anti-β2-glycoprotein I (β2GPI) 223 U/ml; renal pathology suggested lupus nephritis (LN), and the patient was ultimately diagnosed with SLE, secondary APS and LN. The patient was treated with hormones and immunosuppressants. Sixteen weeks later, her urinary protein was 1+, and the quantity of urine protein was less than 0.5 g/d. Echocardiography showed that the mass in the right atrium was thrombotic. Heparin anticoagulant therapy was effective. Conclusion SLE can involve multiple systems and various complications. Thrombus in the right atrium is a rare complication of APS. Early diagnosis and treatment are key to improving the prognosis of children.


Author(s):  
Rana Khudhair Jasim ◽  
Zurina Hassan ◽  
Darshan Singh ◽  
Edward Boyer ◽  
Lay-Harn Gam

2013 ◽  
Vol 6 (1) ◽  
pp. 232 ◽  
Author(s):  
Ariane Vettorazzi ◽  
Robin Wait ◽  
Judit Nagy ◽  
Jose Monreal ◽  
Peter Mantle

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1495.1-1495
Author(s):  
Z. Wailinn ◽  
C. Soe ◽  
H. M. Win

Background:SLE is a chronic inflammatory immunologic abnormalities disease which produce a number of antinuclear antibodies. The SLE renal involvement is clinically apparent in approximately 50% patients (Norby et al., 2017). It is very important to introduce the prompt treatment to prevent the permanent end stage renal disease.Objectives:This study aimed to identify the serum biomarkers that correlate with pretreatment disease activity in patients with SLE nephropathy and predict the treatment outcome so that we may identify the unresponsive cases and switch to the other biologic agents like anti-TWEAK monoclonal antibody in the future.Methods:This was a hospital-based prospective analytical study conducted from January 2018 to November 2019 in Rheumatology Department, Yangon Specialty Hospital. 88 SLE nephropathy patients with 24-hour urinary protein above 0.5g/day planned to have 6 months course of IV cyclophosphamide were enrolled. The paired serum sample of each patient was analyzed by ELISA twice to get the mean serum TWEAK value. Pretreatment SLE disease activity was assessed by the SLEDAI 2k. After the completion of 6 months of aggressive treatment, the treatment response was assessed by measuring the 24 hour urinary protein.Results:Among the 88 patients, 63 patients (71.6%) had completed total 6-months course and 25 patients (28.4%) had not completed:11 patients (12.5%) expired and 2 patients (2.27%) had been changed to other DMARD and 12 patients (13.63%) did not attend the follow up clinic. The mean serum TWEAK level was 856 ± 77 pg/ml in 88 patients. According to the range of serum TWEAK level, most of the patients had serum TWEAK level of 601-900 pg/ml (53.4% of the study population). There was positive correlation between pre-treatment SLEDAI 2k score and pretreatment serum TWEAK level (r=0.464 and P <0.001). When the SLEDAI 2k score was grouped into mild, moderate, high and very high disease activity, the serum TWEAK level also had positive association with the different levels of disease activity (p<0.001). Among 63 treatment completed patients, 55 patients (87.3%) were the treatment responders but 8 patients (12.7%) were treatment non-responders. There was significant difference in the pretreatment SLEDAI 2k in terms of disease activity between treatment responder and treatment non-responder (p<0.001). There was significant difference in the pretreatment SLEDAI 2k in terms of reduction in 24-hours urinary protein between treatment responder and treatment non-responder (p<0.001). There was no significant difference in the level of pretreatment serum TWEAK level between treatment responders and treatment non responders (p=1.000). There was also no significant difference in the pretreatment serum TWEAK level between treatment responders and treatment non-responders in terms of reduction in 24 hours urinary protein (p=0.804).Conclusion:Although the pretreatment serum TWEAK level had a positive correlation with pretreatment disease activity of SLEDAI 2k, it did not reflect the outcome of the responsiveness to the intensive therapy.References:[1]Norby, et al (2017) Outcome in biopsy-proven lupus nephritis: evaluation of biopsies from the Norwegian kidney biopsy registry.Lupus; 26:88Acknowledgments:Prof.Chit Soe, Prof.Hlaing Mya WinDisclosure of Interests:None declared


2020 ◽  
Vol 7 (1) ◽  
pp. 3593-3601
Author(s):  
Ying-Hui Teh ◽  
Xuan-Yi Sim ◽  
Yan-Fen Lee ◽  
Waqas Ahmad ◽  
Vikneswaran Murugaiyah ◽  
...  

Background: Type 2 Diabetes is the most common form of diabetes mellitus, accounting for 90% of all types of diabetes. Diet is one of the important factors affecting the progression of the disease. Methods: In this study, we used urinary protein profile to evaluate the progression of pre-diabetic to diabetic state. Urinary protein profile of pre-diabetic rats with various diet conditions and with or without metformin treatment were compared to those of healthy rats and diabetic rats. Results: It was shown that there were distinct bands that could differentiate the healthy rats from the diabetic ones, namely the protein bands at MW 350 kDa, 280 kDa and 85 kDa (for healthy rats), and protein bands at MW 170 kDa, 51 kDa and 46 kDa (for diabetic rats). In addition, the differentially excreted proteins at MW 62 kDa and 25 kDa (between healthy and diabetic rats) could also be used as indicators. Using the unique band indicators, the pre-diabetic urinary profile was shown to be similar to that of healthy rats. However, by using the differential protein indicators, the band intensity of the 62 kDa, 25 kDa and 17 kDa bands of pre-diabetic rats, with normal diet and metformin treatment, was more similar to that of the healthy rats with normal diet. However, the profile of pre-diabetic rats with high fat diet (with or without metformin treatment) and of pre-diabetic rats (with normal diet without metformin treatment) were more similar to that of diabetic rats. Conclusion: Using this protein profiling comparison method, it was demonstrated that early metformin treatment and controlled diet intake are important in delaying the progression of the pre-diabetic to diabetic state.  


2021 ◽  
Vol 41 ◽  
Author(s):  
Pillar G. Valle ◽  
Júlio C.C. Veado ◽  
Vitor M. Ribeiro ◽  
Pedro P.A. Teles ◽  
Adriane P. Costa Val ◽  
...  

ABSTRACT: In the search for an early biomarker of renal injury, this study aimed to determine the urinary protein profile of dogs with leishmaniasis without treatment and treated as determined by Brazilian legislation. The identification of proteinuria, its classification and the circumstances in which it takes place instigated this study. For this, 30 dogs from an outpatient clinic at a Veterinary Hospital in Belo Horizonte were evaluated. All animals underwent clinical and laboratory tests, which included renal biomarkers. The proteins were characterized using the SDS-page electrophoresis technique, and thus, a urinary protein profile was developed comparing patients considered clinically healthy with dogs infected with leishmaniasis that were under treatment and with untreated infected dogs. The results showed that the hematological and biochemical parameters showed similar behavior between the groups of healthy dogs and dogs with leishmaniasis treated, however a very heterogeneous pattern of urinary proteins can be observed and differed between healthy animals and animals with leishmaniasis, as well as between treated and untreated animals. The results suggest that the classification of proteinuria can be a tool that helps in the staging of animals infected with L. infantum and can differentiate them as to the severity of existing kidney injuries.


Sign in / Sign up

Export Citation Format

Share Document